A detailed history of Optiver Holding B.V. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Optiver Holding B.V. holds 401 shares of GH stock, worth $8,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares
401
Holding current value
$8,737
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $6,444 - $12,767
401 New
401 $11,000
Q2 2022

Aug 10, 2022

SELL
$28.82 - $77.35 $5,187 - $13,922
-180 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $8,685 - $18,088
180 New
180 $12,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.